Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06097637
Other study ID # 2023-139A-YJ01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 19, 2023
Est. completion date August 31, 2026

Study information

Verified date October 2023
Source Ningbo No. 1 Hospital
Contact Lei Xu
Phone +8613486659126
Email xulei22@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Endoscopic resection of pedicled polyps mainly focuses on how to prevent bleeding, and also needs to pay attention to the convenience of resection and the integrity of resection, which means that different endoscopic resection strategies should be adopted for pedicled polyps with different pedicle sizes. The head larger than 20mm or pedicle larger than 5mm are defined as large pedicle polyps, which are at greater risk of bleeding. Current guidelines recommend hot removal by snare following preoperative saline injection, ligation of the pedicle with a nylon ring or metal clip, depending on the size of the polyp head and pedicle. However, the use of snares and metal clamps does not appear to reduce delayed postoperative bleeding, and the technical requirements of nylon ligation are relatively high. Recent studies have found that Underwater endoscopic mucosal resection (UEMR) is also safe and effective for the treatment of large and medium colorectal stemless polyps. Therefore, it is still necessary to further explore new safe and effective endoscopic resection strategies and techniques.


Recruitment information / eligibility

Status Recruiting
Enrollment 156
Est. completion date August 31, 2026
Est. primary completion date August 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - 1. Patients undergoing endoscopic resection of small and medium pedicled polyps in the First Affiliated Hospital of Ningbo University from October 2023 to August 2026; 2. Age 18-75 years old; 3. Patients who voluntarily agreed to participate in this study and signed informed consent. Exclusion Criteria: - 1. Persons under 18 years of age 2. Persons unwilling or unable to provide informed consent 3. Treatment or radiotherapy for malignant diseases, severe chronic heart or lung diseases, coronary or cerebrovascular events requiring hospitalization within the last 3 months 4.Malignant polyps have infiltrated the pedicle 5. Abdominal symptoms such as severe abdominal pain, abdominal distension, and nausea 6.Patients with inadequate intestinal preparation 7. Patients with lifelong anticoagulant therapy or severe bleeding diseases, patients who have recently taken anticoagulant drugs or antiplatelet drugs (within 1 week) 8.Pregnant or lactating

Study Design


Related Conditions & MeSH terms


Intervention

Other:
underwater endoscopic mucosal resection
underwater endoscopic mucosal resection achieves similar rates of complete resection with comparable safety, with lower rates of recurrence and fewer repeat procedures.
hot snare polypectomy
Current guidelines recommend preoperative hot snare polypectomy after preoperative saline injection, nylon ring, or metal clip ligation of the tip and pedicle of the polyps

Locations

Country Name City State
China Ningbo first hospital Ningbo Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Ningbo No. 1 Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Immediate perforation rate perforation 30 seconds
Primary Prevalence of immediate bleeding Immediate bleeding was defined as an intraoperative bleeding immediately after polypectomy. Level 2, Level 1 was defined as continuous exudation for 1 minute, and level 2 was defined as active blood spray 1 Minutes
Secondary delayed hemorrhage Any symptoms of gastrointestinal bleeding (e. g. hematochezia) occurred within 30 days after polypectomy and were classified as mild or severe according on the severity of the bleeding 2 weeks and 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT02203968 - Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST) Phase 1/Phase 2
Recruiting NCT06097650 - Cold Snare Polypectomy Versus Hot Snare Polypectomy for Resection of Small Pedunculated Colorectal Polyps:a Randomized Controlled Trial N/A
Completed NCT01938768 - Effects of an Early Prehospital Administration of Tranexamic Acid on Hyperfibrinolysis in Multiple Trauma N/A
Completed NCT02765022 - Clip Closure of Mucosal Defects After Endoscopic Mucosal Resection. N/A
Completed NCT01629381 - Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy Phase 2
Terminated NCT01961804 - PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma Phase 3
Completed NCT02106000 - A Non-investigational Product (IP) Study to Investigate Lung Function in Women in the Third Stage of Labour N/A
Completed NCT02480556 - Comparing Blood Loss During Caesarean Section Between Manual Separation of Placenta & Conservative Management N/A
Completed NCT02344069 - Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage Phase 2
Completed NCT00440401 - TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM) Phase 4
Completed NCT02745041 - Fibrinogen Early In Severe Trauma studY Phase 2